Manufacturer record
Visa Drugs & Pharmaceuticals Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
1 batch manufactured by Visa Drugs & Pharmaceuticals Pvt. Ltd (Himachal Pradesh) was declared Not of Standard Quality in July 2020. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: VG8034, Ramigal 5 (Ramipril Tablets I.P. 5 mg) (exp Sep 2021). CDL Kolkata (CDSCO lab) found it not of standard quality: Assay. Listed in the July 2020 alert.
Records by type
1 record linked to Visa Drugs & Pharmaceuticals Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ramigal 5 (Ramipril Tablets I.P. 5 mg) | Batch VG8034Mfg Oct 2018 · Exp Sep 2021 | AssayAssay | CDL KolkataCDSCO lab | Jul 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.